$1.39
+7.0%Rafael Holdings, Inc. holds interests in clinical and early stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. The company operates in two segments, Pharmaceuticals and Real Estate. It engages in the leasing of a commercial office building, as well as an associated 800-car public garage; and development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company's lead drug candidate is CPI-613 (devimistat), which is being evaluated in various clinical studies, including two Phase III registrational clinical trials for the treatment of metastatic pancreatic cancer and r/r acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.
No Dividend Yield Data
RFL has not reported any dividend yield values in the available annual periods.
No Dividend Payout Ratio Data
RFL has not reported any dividend payout ratio values in the available annual periods.
No Net Dividends Paid Data
RFL has not reported any net dividends paid values in the available annual periods.
Total Payments
2
Latest Dividend
$0.0200
Annual Amount
$0.0400
Frequency
Semi-Annual
| Declaration | Ex-Date | Payment Date | Dividend | Adjusted | Frequency | Growth |
|---|---|---|---|---|---|---|
N/A | Dec 18, 2009 | Dec 31, 2009 | $0.0200 | $0.0200 | Semi-Annual | 0.00% |
Jun 19, 2009 | Jun 19, 2009 | Jun 30, 2009 | $0.0200 | $0.0200 | Quarterly | - |
Conservative payout with excellent safety margin. Company retains significant earnings for growth, acquisitions, or building cash reserves. Dividend is highly sustainable.
Negative free cash flow while paying dividends is a major red flag. Company burning cash and cannot sustain dividend without external financing.
Dividend appears unsustainable based on current metrics. High probability of reduction or elimination. Proceed with caution.
Continue your RFL research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.